IKS Health sets Sep 21 AGM; FY26 revenue rises 20% to ₹31,938 million
- Inventurus Knowledge Solutions sets 20th AGM for September 21, 2026 via video conferencing
- Consolidated FY26 revenue rose 20% YoY to ₹31,938 million; PAT surged 48% to ₹7,216 million
- Net debt dropped 55.4% to ₹2,510 million driven by ₹6,129 million free cash flow
- Board proposes leaving vacancy unfilled after Berjis Desai retires; Amit Goela seeks reappointment

*this image is generated using AI for illustrative purposes only.
Inventurus Knowledge Solutions has scheduled its 20th Annual General Meeting for Monday, September 21, 2026 at 5:30 pm IST via video conferencing, coinciding with the release of its FY26 annual report showing consolidated revenue of ₹31,938 million, up 20% year-on-year.
Shareholders holding equity as of the September 14, 2026 cut-off date can participate. Remote e-voting opens on Thursday, September 17, 2026 at 9:00 am and closes on Sunday, September 20, 2026 at 5:00 pm. Members can access the meeting through the NSDL e-voting platform at https://www.evoting.nsdl.com . The company also confirmed that physical copies of the Annual Report and AGM Notice were sent to members who have not registered email addresses, in compliance with Regulation 36(1)(b) of SEBI LODR Regulations.
FY26 Financial Performance
The company delivered strong financial results, with profitability growing faster than revenue across all key metrics.
| Metric | FY26 | FY25 | Change |
|---|---|---|---|
| Revenue from operations | ₹31,938 million | ₹26,640 million | +19.9% |
| EBITDA | ₹10,913 million | ₹7,911 million | +38.0% |
| Profit after tax | ₹7,216 million | ₹4,861 million | +48.4% |
| EBITDA margin | 34.2% | 29.7% | +450 bps |
| PAT margin | 22.6% | 18.2% | +440 bps |
| Free cash flow | ₹6,129 million | ₹2,755 million | +122.5% |
| Net debt | ₹2,510 million | ₹5,627 million | -55.4% |
Founder and Global CEO Sachin K. Gupta noted that the company delivered ₹3,194 crore in revenue representing 20% year-on-year growth, with EBITDA growing 38% and PAT surging 48%. Free cash flow yield reached 84.95%, enabling rapid debt reduction from a peak of ₹8,507 million to ₹2,510 million.
Strategic Acquisitions in FY26
FY26 was marked by two transformative acquisitions that completed the company's full-stack healthcare operating system.
| Acquisition | Completion | Enterprise Value | Strategic Role |
|---|---|---|---|
| ARAI Solutions | May 2026 | $1.2 million (IP buy) | Intelligence layer — glass-box AI, clinical ontologies |
| TruBridge, Inc. | July 9, 2026 | $557 million | System of record — EHR for rural and community hospitals |
The TruBridge acquisition secured a leading electronic health record trusted by 700+ rural and community hospitals, covering 5 million+ patient records and serving 20% of the US population in rural areas. The deal is immediately EPS accretive and unlocks a $600 million immediately addressable TAM within the captive TruBridge install base. Currently, 70% of TruBridge EHR clients do not use their RCM services, representing an immediate cross-sell opportunity.
The ARAI acquisition added proprietary biomedical knowledge graphs and clinical ontologies, transitioning the platform from black-box AI to glass-box AI where every clinical prediction is transparent, traceable, and auditable. ARAI's efficiency metrics include a 30% reduction in tokens required for AI tasks and 30-40% projected reduction in claim denial rates.
Board and Governance Changes
The AGM will address ordinary business including adoption of audited financial statements for FY26. Mr. Amit Goela retires by rotation and seeks reappointment as a non-executive nominee director; he received sitting fees of ₹0.24 million in FY25-26.
Mr. Berjis Desai also retires by rotation but does not offer himself for reappointment, and the board has proposed leaving the resulting vacancy unfilled. The board has designated Mr. Clarence Carleton King II as Non-Executive Chairman and Independent Director with effect from the conclusion of the AGM.
Employee Stock Option Plan Amendments
Two special resolutions seek shareholder approval on ESOP matters:
- Increase the ESOP pool from 27,000,000 to 32,000,000 options, each convertible into one fully paid-up equity share of ₹1 face value
- Extend ESOP benefits to employees of group companies, subsidiaries, and associate companies in India and abroad, in compliance with SEBI Share Based Employee Benefits Regulations
The board approved both proposals at its meeting on August 5, 2026, based on the recommendation of the Nomination and Remuneration Committee.
Financial Highlights
The board did not declare a dividend for FY26. There are no unclaimed or unpaid dividends from previous years. On a standalone basis, revenue for FY26 was ₹14,914 million, up 53.26% over FY25, with standalone PAT of ₹5,665 million, up 70.66%.
The company has set a FY30 target of tripling EBITDA to ₹3,000 crore while returning net debt to near-zero levels, supported by a 10-year track record of 28.7% revenue CAGR and 46.4% PAT CAGR.
Meeting Logistics
Institutional shareholders must submit board resolutions authorising their representatives to the scrutinizer at vickyscrutinizer@gmail.com with a copy to evoting@nsdl.com . The registered office in Navi Mumbai serves as the deemed venue for the virtual meeting.
| Parameter | Details |
|---|---|
| AGM date and time | Monday, September 21, 2026 at 5:30 pm IST |
| Mode | Video Conferencing / OAVM |
| Cut-off date | Monday, September 14, 2026 |
| E-voting start | Thursday, September 17, 2026 at 9:00 am IST |
| E-voting end | Sunday, September 20, 2026 at 5:00 pm IST |
| E-voting event number | 141143 |
| Platform | https://www.evoting.nsdl.com |
Source: https://lodr-files.dhan.co/lodr-inputs/Company/INE115Q01022/4b760bd7-476d-4c13-807e-3e4fc23f8248.pdf
Historical Stock Returns for Inventurus Knowledge Solutions
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +3.67% | +8.68% | +8.49% | +45.39% | +29.32% | -1.18% |
How will the integration of TruBridge's EHR system with Inventurus's RCM services impact customer retention rates and average revenue per user in the rural US market?
What specific operational synergies are expected from the ARAI acquisition to achieve the projected 30-40% reduction in claim denial rates within the first 12 months?
Given the decision to forgo a dividend in FY26, how does management plan to balance capital allocation between debt reduction, further acquisitions, and potential share buybacks to meet the FY30 net debt target?


































